Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Hallmann, Anna Lena ^a,b   Araúzo Bravo, Marcos J ^c,d   Mavrommatis, Lampros ^a,e   Ehrlich, Marc ^a,b   Röpke, Albrecht ^f   Brockhaus, Johannes ^f   Missler, Markus ^f   Sterneckert, Jared ^g   Schöler, Hans R ^a,f   Kuhlmann, Tanja ^b   Zaehres, Holm ^a,e   Hargus, Gunnar ^a,b,h  

^a MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^d BASQUE FOUNDATION FOR SCIENCE   (Spain)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f UNIVERSITY OF MÜNSTER   (Germany)

^g CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^h Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXA2 PROTEIN, HUMAN; ISOPROTEIN; LIPOCORTIN 2; TAU PROTEIN; TRANSCRIPTOME;

ASTROCYTE; BIOLOGICAL MODEL; CELL DIFFERENTIATION; COCULTURE; CYTOLOGY; FRONTOTEMPORAL DEMENTIA; GENETICS; HUMAN; INDUCED PLURIPOTENT STEM CELL; METABOLISM; NERVE CELL; NEURAL STEM CELL; OXIDATIVE STRESS; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; UBIQUITINATION;

ANNEXIN A2; ASTROCYTES; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; FRONTOTEMPORAL DEMENTIA; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MODELS, BIOLOGICAL; NEURAL STEM CELLS; NEURONS; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; TAU PROTEINS; TRANSCRIPTOME; UBIQUITINATION;

EID: 85014731020     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep42991     Document Type: Article

References (32)

1. Boxer, A. L. & Miller, B. L. Clinical features of frontotemporal dementia. Alzheimer Dis Assoc Disord 19 Suppl 1, S3 (2005).
2. Goedert, M. & Spillantini, M. G. Pathogenesis of the tauopathies. J Mol Neurosci 45(3), 425 (2011).
3. Noble, W., Hanger, D. P., Miller, C. C. & Lovestone, S. The importance of tau phosphorylation for neurodegenerative diseases. Front Neurol 4, 83 (2013).
4. Ghetti, B. et al. Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Neuropathol Appl Neurobiol 41(1), 24 (2015).
5. Di Giorgio, F. P., Boulting, G. L., Bobrowicz, S. & Eggan, K. C. Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 3(6), 637 (2008).
6. Phatnani, H. & Maniatis, T. Astrocytes in neurodegenerative disease. Cold Spring Harb Perspect Biol 7(6) (2015).
7. Pekny, M. et al. Astrocytes: a central element in neurological diseases. Acta Neuropathol 131(3), 323 (2016).
8. Reinhardt, P. et al. Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. PLoS One 8(3), e59252 (2013).
9. Hargus, G. et al. Origin-dependent neural cell identities in differentiated human iPSCs in vitro and after transplantation into the mouse brain. Cell Rep 8(6), 1697 (2014).
10. Ehrlich, M. et al. Distinct Neurodegenerative Changes in an Induced Pluripotent Stem Cell Model of Frontotemporal Dementia Linked to Mutant TAU Protein. Stem Cell Reports 5(1), 83 (2015).
11. Fong, H. et al. Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells. Stem Cell Reports 1(3), 226 (2013).
12. Iovino, M. et al. Human stem cell-derived neurons: a system to study human tau function and dysfunction. PLoS One 5(11), e13947 (2010).
13. Iovino, M. et al. Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations. Brain 138 (Pt 11), 3345 (2015).
14. Schroder, M. & Kaufman, R. J. The mammalian unfolded protein response. Annu Rev Biochem 74, 739 (2005).
15. Jansen, A. H., Reits, E. A. & Hol, E. M. The ubiquitin proteasome system in glia and its role in neurodegenerative diseases. Front Mol Neurosci 7, 73 (2014).
16. Lam, A. G. et al. Mechanism of glial activation by S100B: involvement of the transcription factor NFkappaB. Neurobiol Aging 22(5), 765 (2001).
17. Angelucci, F. et al. The effect of neuropeptide Y on cell survival and neurotrophin expression in in-vitro models of Alzheimer's disease. Can J Physiol Pharmacol 92(8), 621 (2014).
18. Fuchs, J. et al. Engrailed signaling in axon guidance and neuron survival. Eur J Neurosci 35(12), 1837 (2012).
19. Galvin, J. E. et al. The muscle protein dysferlin accumulates in the Alzheimer brain. Acta Neuropathol 112(6), 665 (2006).
20. Luo, M. & Hajjar, K. A. Annexin A2 system in human biology: cell surface and beyond. Semin Thromb Hemost 39(4), 338 (2013).
21. Kalman, M. & Szabo, A. Appearance of annexin II immunopositivity in reactive astrocytes but not in microglia. Neurobiology (Bp) 9(3-4), 139 (2001).
22. Gauthier-Kemper, A. et al. The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner. J Cell Biol 192(4), 647 (2011).
23. Lu, T. et al. Gene regulation and DNA damage in the ageing human brain. Nature 429(6994), 883 (2004).
24. Slowinski, J. et al. Frontotemporal dementia and Parkinsonism linked to chromosome 17 with the N279K tau mutation. Neuropathology 27(1), 73 (2007).
25. Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337(6096), 816 (2012).
26. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339(6121), 819 (2013).
27. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339(6121), 823 (2013).
28. Zwaka, T. P. & Thomson, J. A. Homologous recombination in human embryonic stem cells. Nat Biotechnol 21(3), 319 (2003).
29. Mandal, P. K. et al. Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. Cell Stem Cell 15(5), 643 (2014).
30. Koch, P. et al. A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration. Proc Natl Acad Sci USA 106(9), 3225 (2009).
31. Rabinovich-Nikitin, I. et al. Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALS. J Neuroinflammation 13(1), 123 (2016).
32. Mishra, M. et al. Gene expression analysis of frontotemporal lobar degeneration of the motor neuron disease type with ubiquitinated inclusions. Acta Neuropathol 114(1), 81 (2007).